Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

nude mice

  • Open Access
    Ultra-low Concentrations of Cisplatinum Down to the IC10 in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo
    YOHEI ASANO, QINGHONG HAN, SHUKUAN LI, BYUNG MO KANG, JIN SOO KIM, YUTA MIYASHI, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, SEI MORINAGA, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    In Vivo March 2026, 40 (2) 803-812; DOI: https://doi.org/10.21873/invivo.14238
  • Open Access
    HT1080 Human Fibrosarcoma Cells Selected for Super-eribulin Resistance In Vitro Become More Malignant and Are Arrested Synergistically by Methionine Restriction in Combination With Eribulin in Nude Mice
    SEI MORINAGA, KOHEI MIZUTA, BYUNG MO KANG, QINGHONG HAN, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    In Vivo May 2025, 39 (3) 1275-1282; DOI: https://doi.org/10.21873/invivo.13931
  • Open Access
    The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo
    SEI MORINAGA, MING ZHAO, KOHEI MIZUTA, BYUNG MO KANG, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    In Vivo January 2025, 39 (1) 102-109; DOI: https://doi.org/10.21873/invivo.13807
  • Open Access
    Accurate and Safe Tumor Targeting of Orally-administered Salmonella typhimurium A1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude Mice
    SEI MORINAGA, MING ZHAO, KOHEI MIZUTA, BYUNG MO KANG, MOTOKAZU SATO, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    In Vivo November 2024, 38 (6) 2601-2609; DOI: https://doi.org/10.21873/invivo.13736
  • Open Access
    Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model
    MOTOKAZU SATO, KOHEI MIZUTA, QINGHONG HAN, SEI MORINAGA, BYUNG MO KANG, YUTARO KUBOTA, RYOSUKE MORI, ANTON BARANOV, KEITA KOBAYASHI, DANIEL ARDJMAND, NORITOSHI KOBAYASHI, MICHAEL BOUVET, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN
    In Vivo May 2024, 38 (3) 1058-1063; DOI: https://doi.org/10.21873/invivo.13539
  • Open Access
    Precise and Facile Endotracheal Lung-tumor-implantation Mouse Model Visualized by GFP Expression
    YUSUKE AOKI, KEITA J. KOBAYASHI, NUNDINI VARSHNEY, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, JUSTIN D. WANG, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN
    In Vivo July 2023, 37 (4) 1477-1481; DOI: https://doi.org/10.21873/invivo.13231
  • Open Access
    Oral-recombinant Methioninase Lowers the Effective Dose and Eliminates Toxicity of Cisplatinum for Primary Osteosarcoma of the Mammary Gland in a Patient-derived Orthotopic Xenograft Mouse Model
    NORIYUKI MASAKI, QINGHONG HAN, NATHANIEL F. WU, CARISSA SAMONTE, JUSTIN WU, CHIHIRO HOZUMI, KOYA OBARA, YUTARO KUBOTA, YUSUKE AOKI, JUN MIYAZAKI and ROBERT M. HOFFMAN
    In Vivo November 2022, 36 (6) 2598-2603; DOI: https://doi.org/10.21873/invivo.12994
  • You have access
    A Non-invasive Imageable GFP-expressing Mouse Model of Orthotopic Human Bladder Cancer
    YU SUN, HIROTO NISHINO, MING ZHAO, KENTARO MIYAKE, NORIHIKO SUGISAWA, JUN YAMAMOTO, YOSHIHIKO TASHIRO, SACHIKO INUBUSHI, KAZUYUKI HAMADA, GUANGWEI ZHU, HYEIN LIM and ROBERT M. HOFFMAN
    In Vivo November 2020, 34 (6) 3225-3231; DOI: https://doi.org/10.21873/invivo.12158
  • You have access
    Co-implantation of Tumor and Extensive Surrounding Tissue Improved the Establishment Rate of Surgical Specimens of Human-Patient Cancer in Nude Mice: Toward the Goal of Universal Individualized Cancer Therapy
    TAKUYA MURATA, CHIHIRO HOZUMI, YUKIHIKO HIROSHIMA, KOICHIRO SHIMOYA, ATSUSHI HONGO, SACHIKO INUBUSHI, HIROKAZU TANINO and ROBERT M. HOFFMAN
    In Vivo November 2020, 34 (6) 3241-3245; DOI: https://doi.org/10.21873/invivo.12160
  • You have access
    Humanized Fluorescent Tumor-associated Glycoprotein-72 Antibody Selectively Labels Colon-cancer Liver Metastases in Orthotopic Mouse Models
    HANNAH M. HOLLANDSWORTH, HIROTO NISHINO, MICHAEL TURNER, SIAMAK AMIRFAKHRI, FILEMONI FILEMONI, ROBERT M. HOFFMAN, PAUL J. YAZAKI and MICHAEL BOUVET
    In Vivo September 2020, 34 (5) 2303-2307; DOI: https://doi.org/10.21873/invivo.12042

Pages

  • Next
  • 1
  • 2
In Vivo

© 2026 In Vivo

Powered by HighWire